Hypogammaglobulinemia Clinical Trials
20 clinical trials for Hypogammaglobulinemia across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections — RECRUITING · PHASE3
- A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma — RECRUITING · PHASE3
- Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)? — RECRUITING
- Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia — RECRUITING · PHASE2
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension — RECRUITING · PHASE2
- Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome — COMPLETED · PHASE2
- Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) — COMPLETED · PHASE3
- Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia) — COMPLETED · PHASE2
- Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) — COMPLETED · PHASE3
- Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis — OTHER
- Immunodeficiency in MS — OTHER
- Personalized Immunotherapeutic for Antibiotic-resistant Infection — COMPLETED · PHASE1
- Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients — COMPLETED · NA
- Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — COMPLETED · PHASE2
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation — COMPLETED · PHASE2
- Post-bypass Prophylactic IVIG in Infants and Neonates — COMPLETED · NA
- Investigation of Immune Disorders and Deficiencies — OTHER
- Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. — COMPLETED · PHASE3
- Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients — COMPLETED · PHASE2
- Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients — COMPLETED · PHASE2
Refine this search